Microbial preparation for preventing and treating mastitis and applications thereof
A technology of microbial preparations and mastitis, applied in the field of microbial preparations, can solve problems such as low production efficiency, incompatibility, and labor consumption, and achieve the effects of wide application range, significant effect, and overcoming side effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0038] (1) Preparation of microbial preparations for preventing and treating mastitis
[0039] The Bdellovibrio strains used were Bdellovibrio BDS01 and Bdellovibrio BDS02, respectively. Bdellovibrio BDS01 was preserved in the China Center for Type Culture Collection on August 7, 2009, and the preservation number is CCTCC NO: M 209169; after negative staining of the Bdellovibrio BDS01, the morphology was observed under an electron microscope: BDS01 showed a single The cells are arc-shaped, with a size of 0.9×0.25 μm, terminal flagella, and the length of the flagella is 4 μm. They can form transparent circular plaques with a diameter of 1-2 mm when cultured at 28° C. for four days by double-layer plate method. The Bdellovibrio BDS02 was preserved in the China Center for Type Culture Collection on August 7, 2009, and the preservation number is CCTCCNO: M 209170; after the Bdellovibrio BDS02 was negatively stained, the morphology was observed under an electron microscope: BDS02 w...
Embodiment 2
[0063] Microbial preparations are used to treat small-tailed cold sheep infected with mastitis, and the specific process is as follows:
[0064] A, test drug: experimental group: the microbial preparation that embodiment 1 step (1) prepares
[0065] Control group: ciprofloxacin lactate (produced by Luoyang Huizhong Veterinary Medicine Co., Ltd.);
[0066] B. Treated cases: A total of 120 cases of clinical mastitis were treated, including 20 cases in the ciprofloxacin lactate group and microbial preparations A, B, C, D, and E groups;
[0067] C. Dosage and method: The dosage is as follows: ciprofloxacin lactate 1.5% 10mL; Bdellovibrio 103pfu / ml 1000mL; the medication method is as follows: ① Squeeze the milk first, disinfect the nipple with 75% alcohol by volume, and insert the milk duct For the breast, inject ciprofloxacin lactate, then grasp the nipple and massage the breast sequentially from bottom to top, so that the liquid medicine spreads throughout the breast, 2 times a ...
Embodiment 3
[0073] (1) Preparation of microbial preparations for preventing and treating mastitis in sows
[0074] The preparation process is the same as Example 1 step (1), and the difference is only that the solution of suspended hiruplasma and swimming body used when preparing microbial preparations A, B, C, D, E uses PBS damping fluid (0.2mol / L, pH is 7.2).
[0075] (2) Treatment of pigs infected with mastitis with microbial preparations
[0076] A, test drug: experimental group: microbial preparation prepared in step (1)
[0077] Control group: 0.5-1% procaine hydrochloride, penicillin (produced by Sichuan Dikang Technology Pharmaceutical Co., Ltd.);
[0078] B. Treated cases: A total of 120 cases of clinical mastitis were treated, including 20 cases in the ciprofloxacin lactate group and microbial preparations A, B, C, D, and E groups;
[0079] C. Dosage and method: The dosage is as follows: procaine hydrochloride 0.5-1% 15mL, penicillin 400,000 international units; Bdellovibrio ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap